SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178913-23-002344
Filing Date
2023-06-30
Accepted
2023-06-30 16:06:13
Documents
12
Period of Report
2023-06-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K zk2329931.htm   iXBRL 8-K 29853
  Complete submission text file 0001178913-23-002344.txt   170966

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA entx-20230629.xsd EX-101.SCH 3868
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE entx-20230629_lab.xml EX-101.LAB 23290
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE entx-20230629_pre.xml EX-101.PRE 16554
6 EXTRACTED XBRL INSTANCE DOCUMENT zk2329931_htm.xml XML 4387
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38556 | Film No.: 231061726
SIC: 2836 Biological Products, (No Diagnostic Substances)